Business US

Medicare delays GLP-1 coverage plan; interim program extended

Apr 22, 2026, 9:19 AM ETEli Lilly and Company (LLY) Stock, NVO Stock, UNH Stock, HUM StockCVS, ELV, CNC, MOH, NONOFBy: Dulan Lokuwithana, SA News EditorFollow us on Google for the latest stock news

Bill Oxford

The Trump administration has extended a short-term program that offers Medicare coverage for weight loss drugs such as Novo’s (NVO) Wegovy and Lilly’s (LLY) Zepbound after leading health insurers balked at participating in a long-term payment model.

According to the

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button